| Research Field |
Count |
|
patients |
14 |
|
treatment |
10 |
|
diagnosis |
9 |
|
rats |
9 |
|
Albino Rat |
8 |
|
carcinoma |
8 |
|
Adult Male Albino |
7 |
|
fracture |
7 |
|
risk |
7 |
|
Serum |
7 |
|
cancer |
7 |
|
Protective Role |
6 |
|
adult |
6 |
|
Evaluation |
6 |
|
bladder |
6 |
|
positive liver cirrhosis |
6 |
|
HCV positive liver |
6 |
|
ascitic fluid hepcidin |
6 |
|
aged rats |
5 |
|
cancer patients |
5 |
|
HCC |
5 |
|
Immunohistochemical expression |
5 |
|
Albino Rats |
5 |
|
Notch-1 |
4 |
|
differentiation |
4 |
|
serum glypican-3 |
4 |
|
MTHR polymorphism |
4 |
|
management |
4 |
|
Theophylline Overdose |
4 |
|
ECG |
4 |
|
anterior cruciate ligament |
4 |
|
cruciate ligament reconstruction |
4 |
|
breast cancer |
4 |
|
letrozole |
4 |
|
Immunohistochemical analysis |
4 |
|
albino rat |
4 |
|
Paravertebral Ozone |
4 |
|
Caudal Epidural Corticosteroids |
4 |
|
hepatitis-C virus |
4 |
|
Induced Lung Fibrosis |
3 |
|
shaft fractures |
3 |
|
diabetic foot ulcers |
3 |
|
differential diagnosis |
3 |
|
Ki-67 proliferative Markers |
3 |
|
hepatitis-C virus cirrhosis |
3 |
|
hepatocellular |
3 |
|
Risk |
3 |
|
reactive protein |
3 |
|
Thehomocysteine |
3 |
|
classification |
3 |
